Objective. To assess the longterm safety and efficacy of tocilizumab (TCZ) in patients with
moderate to severe rheumatoid arthritis (RA). Methods. Patient data were from 5 randomized …

Objective To assess the short‐term tolerability of lorcaserin alone or with two dose regimens
of phentermine. Methods This was a 12‐week, randomized, double‐blind, pilot safety study …

The anti-Tac mAb has been shown to bind to the p55 chain of the IL-2R, block IL-2 binding
and inhibit T cell proliferation. A humanized form of anti-Tac (HAT) has been constructed that …

We studied the efficacy and tolerance of humanized Ab interfering with the signal of the IL-2
and IL-15 receptors in a primate model of experimental autoimmune uveoretinitis. The …

Objective Tocilizumab, a monoclonal antibody to interleukin-6 receptor, was recently approved
for the treatment of moderate-to-severe rheumatoid arthritis. Two patients during clinical …

This is an open-label, single-arm, phase 3b study (part of phase 3 development) to evaluate
the efficacy and safety of Fortovase-soft gelatin formulation (saquinavir-SGC), combined …

Objective The objective of this study was to determine whether a triple therapy regimen
incorporating twice-daily saquinavir is as effective as a three-times daily regimen. Methods This …

Objectives To evaluate the long-term efficacy and safety of saquinavir soft gelatin capsules (SQV-SGC)
(Fortovase®) in twice-daily, with or without nelfinavir (NFV), and three-times-daily …

Publisher Summary It has been shown that antigen-specific inducer and suppressor factors
may be isolated from dialysates of leukocyte extracts (DLE) by affinity adsorption and …

DLE was prepared from the minority of euglycemic CD-1 mice, previously injected with STZ,
and was administered to hyperglycemic CD-1 male mice 1, 2 and 3 weeks after completion …